MedTrace Logo

PREVENT: PeRomEter Visualization to ENd Treatment-related Lymphedema

NCT05056207 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2026-03-05

No results posted yet for this study

Summary

This research study is to learn about breast cancer patients' opinions about screening for lymphedema (a side effect of breast cancer treatment in which the arm can become heavy, painful, and/or swollen) and their satisfaction with the lymphedema screening program.

Conditions

  • Lymphedema

Interventions

OTHER

Cohort I (patients receiving annual lymphedema screening

patientns who previously underwent preoperative perometer lymphedema screening

OTHER

Cohort II (patients followed intensively for lymphedema)

patients who have recently undergone ALND

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Simona Shaitelman · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-17
Primary Completion
2026-11-17
Completion
2026-11-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05056207 on ClinicalTrials.gov